These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3803416)

  • 41. Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants.
    Brodie MJ; Forrest G; Rapeport WG
    Br J Clin Pharmacol; 1983 Dec; 16(6):747-9. PubMed ID: 6661364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice.
    Wlaź P; Roliński Z; Czuczwar SJ
    Epilepsia; 1996 Jul; 37(7):610-7. PubMed ID: 8681892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for carbamazepine elevation and toxicity following epilepsy surgery.
    Hiremath GK; Kotagal P; Bingaman W; Hovinga C; Wyllie E; Morris H; Nelson D
    Seizure; 2005 Jul; 14(5):312-7. PubMed ID: 15876544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbamazepine (CBZ) controlled release compared with conventional CBZ: a controlled study of attention and vigilance in children with epilepsy.
    Pieters MS; Jennekens-Schinkel A; Stijnen T; Edelbroek PM; Brouwer OF; Liauw L; Heyer A; Lanser JB; Peters AC
    Epilepsia; 1992; 33(6):1137-44. PubMed ID: 1464276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychomotor impairment and anticonvulsant therapy in adult epileptic patients.
    Brodie MJ; McPhail E; Macphee GJ; Larkin JG; Gray JM
    Eur J Clin Pharmacol; 1987; 31(6):655-60. PubMed ID: 3830252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients.
    Park PW; Seo YH; Ahn JY; Kim KA; Park JY
    J Clin Pharm Ther; 2009 Oct; 34(5):569-74. PubMed ID: 19744012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
    McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anticonvulsant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols.
    Grabenstatter HL; Clark S; Dudek FE
    Epilepsia; 2007 Dec; 48(12):2287-95. PubMed ID: 17711461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbamazepine/valproic acid interaction in man and rhesus monkey.
    Levy RH; Moreland TA; Morselli PL; Guyot M; Brachet-Liermain A; Loiseau P
    Epilepsia; 1984 Jun; 25(3):338-45. PubMed ID: 6426944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute oral loading of carbamazepine-CR and phenytoin in a double-blind randomized study of patients at risk of seizures.
    Van Der Meyden CH; Kruger AJ; Müller FO; Rabie W; Schall R
    Epilepsia; 1994; 35(1):189-94. PubMed ID: 8112244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction of dosing frequency of carbamazepine with a slow-release preparation.
    Sivenius J; Heinonen E; Lehto H; Järvensivu P; Anttila M; Ylinen A; Riekkinen P
    Epilepsy Res; 1988; 2(1):32-6. PubMed ID: 3197677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization.
    Hung CC; Chang WL; Ho JL; Tai JJ; Hsieh TJ; Huang HC; Hsieh YW; Liou HH
    Pharmacogenomics; 2012 Jan; 13(2):159-69. PubMed ID: 22188362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients.
    MacKichan JJ; Duffner PK; Cohen ME
    Br J Clin Pharmacol; 1981 Jul; 12(1):31-7. PubMed ID: 7248139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical monitoring during carbamazepine slow-release, once-daily monotherapy.
    Stefan H; Schäfer H; Kuhnen C; Schneider S
    Epilepsia; 1988; 29(5):571-7. PubMed ID: 3137020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine.
    Persson LI; Ben-Menachem E; Bengtsson E; Heinonen E
    Epilepsy Res; 1990 Jul; 6(2):134-40. PubMed ID: 2201541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of carbamazepine and carbamazepine-epoxide protein binding in patients undergoing epilepsy surgery.
    Gidal BE; Spencer NW; Maly MM; Pitterle ME
    Epilepsia; 1996 Apr; 37(4):381-5. PubMed ID: 8603645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
    Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
    Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time-dependency of serum carbamazepine concentration.
    Suzuki K; Kaneko S; Sato T
    Folia Psychiatr Neurol Jpn; 1978; 32(2):199-209. PubMed ID: 669497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutual interaction between remacemide hydrochloride and carbamazepine: two drugs with active metabolites.
    Leach JP; Blacklaw J; Jamieson V; Jones T; Richens A; Brodie MJ
    Epilepsia; 1996 Nov; 37(11):1100-6. PubMed ID: 8917061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
    Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Ketter TA; Keck PE; Swann A; Kalali A;
    CNS Drugs; 2006; 20(3):219-31. PubMed ID: 16529527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.